These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4148588)

  • 21. [Part II; standardization and normalization of dyes. 12. Introduction: relationship of the dye commission to the professional standards committee in medicine].
    Fasske E
    Acta Histochem; 1973; Suppl 13(0):317-8. PubMed ID: 4214394
    [No Abstract]   [Full Text] [Related]  

  • 22. Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
    Ishizaki T; Sugita M
    Clin Pharmacol Ther; 1974 Sep; 16(3):577-84. PubMed ID: 4415183
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 24. Medicines, governments and doctors.
    Dunlop D
    Drugs; 1972; 3(5):305-13. PubMed ID: 4652594
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs in the E.E.C.
    Lancet; 1972 Apr; 1(7757):944-5. PubMed ID: 4112105
    [No Abstract]   [Full Text] [Related]  

  • 26. Law, medicines and the doctor: a critical look at drug regulation.
    Dukes MN
    Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727
    [No Abstract]   [Full Text] [Related]  

  • 27. The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health.
    Molzon JA; Giaquinto A; Lindstrom L; Tominaga T; Ward M; Doerr P; Hunt L; Rago L
    Clin Pharmacol Ther; 2011 Apr; 89(4):503-12. PubMed ID: 21326288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of food additives and contaminants.
    Goodall HM
    Proc Nutr Soc; 1972 May; 31(1):9-14. PubMed ID: 5048510
    [No Abstract]   [Full Text] [Related]  

  • 30. [Compendium medicamentorum].
    Buriánek J; Hubík J; Parrák V
    Cesk Farm; 1972 Oct; 21(8):337-40. PubMed ID: 5084368
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs and the Washington climate.
    Durant TM
    Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Jul; 109(21):429-31. PubMed ID: 1916572
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential conflict of interest of a pharmacy and therapeutics committee member.
    Am J Hosp Pharm; 1989 Oct; 46(10):2047-9; discussion 2049-51. PubMed ID: 2816960
    [No Abstract]   [Full Text] [Related]  

  • 35. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 36. Communicating adverse drug reactions.
    Lancet; 1978 Jan; 1(8056):133. PubMed ID: 87560
    [No Abstract]   [Full Text] [Related]  

  • 37. The International Conference on Harmonization common technical document--global submission format?
    Molzon JA
    Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular drugs: experience of the Drug Efficacy Study (DES).
    Freis ED; Burchell HB
    Circulation; 1970 Jan; 41(1):3-11. PubMed ID: 4911889
    [No Abstract]   [Full Text] [Related]  

  • 39. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 40. [European efforts in drug problems].
    Bertschinger JP
    Ther Umsch; 1971 Apr; 28(4):220-5. PubMed ID: 5575079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.